| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. is a 10% Owner at CDXS with holdings across 9 companies. Recent SEC Form 4 filings include 13 buys and 19 sells.
Estimated insider holdings value: $139.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 703 | $6.49 | $4,562.47 | - | -25.7% | -57.6% | |
| Dec 17, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 10,353 | $6.46 | $66,898.88 | +0.2% | -25.2% | -54.3% | |
| Nov 18, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 24,324 | $6.98 | $169,773.92 | +0.5% | -24.2% | -53.0% | |
| Nov 17, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 25,000 | $4.67 | $116,712.50 | -1.0% | -16.8% | -36.3% | |
| Nov 16, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 15,438 | $4.85 | $74,877.11 | -0.3% | -23.1% | -35.9% | |
| Nov 8, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 220,362 | $6.25 | $1,377,985.53 | -4.2% | -32.7% | -53.7% | |
| Nov 4, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 6,557 | $6.50 | $42,620.50 | +0.3% | -22.4% | -59.5% | |
| Nov 4, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 202,200 | $6.49 | $1,312,500.75 | -3.5% | -43.1% | -60.9% | |
| Oct 12, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 165,100 | $5.03 | $830,670.47 | -1.8% | -17.2% | -58.9% | |
| Aug 19, 2021 | HROW Harrow, Inc. | - | Buy | 52,500 | $8.45 | $443,362.50 | +1.6% | +29.4% | +1.8% |